DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bsv3x5/global_ent) has announced the addition of the "Global ENT Devices Market 2012-2016" report to their offering.
One of the key factors contributing to this market growth is the advancements in the Cochlear Implant Devices segment. The Global ENT Devices market has also been witnessing an increase in the number of acquisitions and new entrants. However, problems with voice prosthesis and hearing aid device batteries could pose a challenge to the growth of this market.
The key vendors dominating this market space are Cochlear Ltd., Siemens Healthcare, Sonova Holding AG, Starkey Laboratories Inc., Widex A/S, and William Demant Holding A/S.
The other vendors mentioned in the report are GN ReSound A/S, Unitron Hearing Inc., Sonic Innovations Inc., Panasonic Corp., Rexton Inc., Beltone, Miracle-Ear Inc., MED-EL GmbH, Neurelec SA, Nuear Hearing Aids Inc., Bernafon, American Hearing Systems Inc., Audiosync Inc., Zounds Inc., and Avada Hearing Care.
Commenting on the report, an analyst from TechNavio's Healthcare team said: ''The Global ENT Devices market has been experiencing significant growth in the Rechargeable Hearing Aid Devices segment recently. For instance, Hansaton Acoustics Inc. introduced the AQ Custom Rechargeable ITE in 2010 and the AQ X-Mini Rechargeable Receiver-in-the-Canal (RIC) device in July 2011. Sales of rechargeable consumer hearing aid devices possess many advantages compared to the conventional hearing aid devices with primary cells. Rechargeable hearing aid devices are smaller in size, allowing manufacturers to build very small, cosmetically appealing, hearing instruments. Moreover, these rechargeable hearing aid devices are environmentally friendly and easy to use. Further, the quality and the battery life of these devices is estimated to be better compared to the primary cells.
For more information visit http://www.researchandmarkets.com/research/bsv3x5/global_ent